Fig. 2From: The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in CanadaCost-effectiveness plane for as-needed budesonide-formoterol versus low-dose ICS plus as-needed SABA. ICS: inhaled corticosteroid; QALY: quality-adjusted life year; SABA: short-acting β2-agonistBack to article page